New Perspectives in Rheumatology: Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of Antinuclear Antibodies and Anti-DNA-Reference-Cited by-同舟云学术

New Perspectives in Rheumatology: Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of Antinuclear Antibodies and Anti-DNA

Published:2017-02-27 Issue:3 Volume:69 Page:487-493
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Pisetsky David S.¹,Rovin Brad H.²,Lipsky Peter E.³

Affiliation:

1. Duke University Medical Center and Medical Research Service, Durham VA Medical Center; Durham North Carolina

2. The Ohio State University, Wexner Medical Center; Columbus

3. RILITE Foundation; Charlottesville Virginia

Funder

Lupus Industry Council

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.40008/fullpdf

Reference56 articles.

1. Systemic lupus erythematosus;Tsokos;N Engl J Med,2011

2. A critical review of clinical trials in systemic lupus erythematosus;Mahieu;Lupus,2016

3. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis;Appel;J Am Soc Nephrol,2009

4. Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis trial;Houssiau;Ann Rheum Dis,2010

5. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study;Rovin;Arthritis Rheum,2012

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving Drug Trial Success Rates in Systemic Lupus Erythematosus: Endotyping-based Patient Stratification Could be the way Forward;Indian Journal of Rheumatology;2024-02-13

2. Hydrolysis of Oligodeoxyribonucleotides on the Microarray Surface and in Solution by Catalytic Anti-DNA Antibodies in Systemic Lupus Erythematosus;Current Issues in Molecular Biology;2023-12-08

3. Improving Drug Trial Success Rates in Systemic Lupus Erythematosus: Endotyping-based Patient Stratification Could Be the Way Forward;Indian Journal of Rheumatology;2023-11-09

4. Diagnosis of systemic lupus erythematosus in a dog with an atypical presentation of pleuritis;Veterinary Record Case Reports;2023-10-10

5. Antinuclear antibody staining patterns by indirect immunofluorescence assay observed in patients from a tertiary health center in Latin America;Revista Colombiana de Reumatología;2023-06